| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |